Literature DB >> 19081093

Myeloperoxidase overexpression in children with hypercholesterolemia.

P Pignatelli1, L Loffredo, F Martino, E Catasca, R Carnevale, C Zanoni, M Del Ben, R Antonini, S Basili, F Violi.   

Abstract

BACKGROUND: Studies conducted in healthy children showed that biomarkers of oxidative stress decreased with increasing age from 1 to 11 years. No data have been reported concerning the behavior of age-related oxidative stress in hypercholesterolemic children.
OBJECTIVE: Aim of this study was to test if children with hypercholesterolemia have prolonged exposure to enhanced oxidative stress and to study the underlying mechanism.
METHODS: We performed a cross-sectional study comparing 8-hydroxy-2'deoxyguanosine, oxidized-LDL and myeloperoxidase plasma levels in 95 normocholesterolemic and 95 hypercholesterolemic children.
RESULTS: Compared to normocholesterolemic children, those with hypercholesterolemia had higher 8-hydroxy-2'deoxyguanosine, oxidized-LDL and myeloperoxidase plasma levels. A correlation analysis of the overall population showed that total cholesterol was directly correlated with 8-hydroxy-2'deoxyguanosine, oxidized-LDL and myeloperoxidase. Stepwise linear regression showed that only total cholesterol, 8-hydroxy-2'deoxyguanosine and myeloperoxidase levels predicted oxidized-LDL plasma levels. In normocholesterolemic children oxidized-LDL and myeloperoxidase plasma levels significantly decreased from first (1-5 years) to second (6-9 years) quartile of age. In hypercholesterolemic children 8-hydroxy-2'deoxyguanosine, oxidized-LDL and myeloperoxidase plasma levels did not show significant differences among quartiles of age.
CONCLUSION: This study shows that an early and persistent oxidative stress is detected in hypercholesterolemic children and that myeloperoxidase up-regulation might play a role.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19081093     DOI: 10.1016/j.atherosclerosis.2008.10.025

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  Cinnamaldehyde exerts vasculoprotective effects in hypercholestrolemic rabbits.

Authors:  Omnia A A Nour; George S G Shehatou; Mona Abdel Rahim; Mohammed S El-Awady; Ghada M Suddek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-30       Impact factor: 3.000

Review 2.  Vascular endothelial dysfunction and pharmacological treatment.

Authors:  Jin Bo Su
Journal:  World J Cardiol       Date:  2015-11-26

3.  Plant-based, no-added-fat or American Heart Association diets: impact on cardiovascular risk in obese children with hypercholesterolemia and their parents.

Authors:  Michael Macknin; Tammie Kong; Adam Weier; Sarah Worley; Anne S Tang; Naim Alkhouri; Mladen Golubic
Journal:  J Pediatr       Date:  2015-02-12       Impact factor: 4.406

4.  Association between Myeloperoxidase Levels and Risk of Insulin Resistance in Egyptian Obese Women.

Authors:  Moushira Zaki; Walaa Basha; Hanaa Reyad; Ramy Mohamed; Naglaa Hassan; Shams Kholousi
Journal:  Open Access Maced J Med Sci       Date:  2018-04-06

5.  Myeloperoxidase is an early biomarker of inflammation and cardiovascular risk in prepubertal obese children.

Authors:  Josune Olza; Concepcion M Aguilera; Mercedes Gil-Campos; Rosaura Leis; Gloria Bueno; Maria D Martínez-Jiménez; Miguel Valle; Ramon Cañete; Rafael Tojo; Luis A Moreno; Angel Gil
Journal:  Diabetes Care       Date:  2012-08-21       Impact factor: 19.112

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.